Neoplasia/BPH

	Global research trends and thematic evolution in robot-assisted radical nephrectomy: a bibliometric and visualisation study. J Robot Surg Qiu Z, Duan C, Chen K, Yin C. PMID: 42174280 [PubMed - indexed for MEDLINE]
	Omission of indwelling urinary catheter after robotic partial nephrectomy in female patients: a single-surgeon experience. J Robot Surg Choi JW, Saxena S, Rajendran P, Kourouma A, Billah MS, Ahmed M. PMID: 42174186 [PubMed - indexed for MEDLINE]
	Early-access Use of Radioligand Therapy in Prostate Cancer. Eur Urol Focus François C, Bailly C. PMID: 42173792 [PubMed - as supplied by publisher]
	Comment on "Association of cardiovascular-kidney-metabolic syndrome with cardiovascular, cancer, and all-cause mortality among US adults: A prospective study". J Formos Med Assoc Shubham, Mathur A. PMID: 42173781 [PubMed - as supplied by publisher]
	Epigenetic signatures and risk determinants in bladder cancer: Implications for diagnostic and therapeutic interventions. Urol Oncol Pradhan B, Mishra P, Dash P, Niharika, Baral T, Mishra J, Chakraborty S, Nandi P, Patra SK. PMID: 42173769 [PubMed - as supplied by publisher]
	Racial and ethnic differences in prostate cancer screening outcomes in the United States: A secondary analysis of the prostate, lung, colorectal, and ovarian cancer trial. Prev Med Joung HH, Martin DN, Jones RA. PMID: 42173201 [PubMed - as supplied by publisher]
	Prostate imaging after focal ablation scoring after irreversible electroporation treatment in localized prostate cancer: Diagnostic accuracy and inter-reader agreement. Eur J Radiol Altan SA, Sakar R, Onay A, Kizil PG, Mercan ED, Gunhan O, Adsan O. PMID: 42172740 [PubMed - as supplied by publisher]
	Environmental Nonessential Element Exposure and Urologic Cancer: A Systematic Review and Meta-Analysis. JAMA Netw Open Deng Z, Li J, Ji R, Delgado JR, Yim SHL, Kachuri L, Cardenas A, Graff RE, Leppert JT, Dennis LK, Chung BI, Langston ME. PMID: 42172026 [PubMed - indexed for MEDLINE]
	TFPI2 expression predicts resistance to immunotherapy plus tyrosine kinase inhibitor and informs first-line therapy selection in metastatic renal cell carcinoma. Cell Oncol (Dordr) Wang J, Du L, Wang Y, Wang H, Zhu Y, Xu X. PMID: 42171882 [PubMed - as supplied by publisher]
	Renal function outcomes following endoscopic management of upper tract urothelial carcinoma. World J Urol Korn P, Essien M, Pallauf M, Cheaib J, Lokeshwar S, Herrera-Caceres JO, Small A, Raskolnikov D, Kleinmann N, Shvero A, Matin SF, Labbate C, Kaimakliotis H, Tachibana I, Linehan J, Choe J, Shah O, Movassaghi M, Huang W, Persily J, Perecman A, Canes D, Pessoa RR, Potretzke A, Raman JD, Singla N. PMID: 42171772 [PubMed - indexed for MEDLINE]
	Perirectal spacers and endorectal balloons in external beam radiotherapy for prostate cancer: aÂ review of prospective studies. Strahlenther Onkol Moll M, Mendenhall NP, Goldner G, Miszczyk M, Sushant S, Lütgendorf-Caucig C, Hug E, Mendenhall WM. PMID: 42171762 [PubMed - as supplied by publisher]
	First-Line Systemic Treatments for Metastatic Hormone-Sensitive Prostate Cancer: Updated Systematic Review and Network Meta-analysis. J Urol Miyajima K, Miszczyk M, Matsukawa A, Roessler N, Inoue S, Urabe F, Mori K, Yanagisawa T, Karakiewicz PI, Agarwal N, Briganti A, Kimura T, Shariat SF. PMID: 42171515 [PubMed - as supplied by publisher]
	Interplay of the 3D genome and epigenome in androgen-driven prostate cancer. Epigenomics Campbell EM, Challis D, Clark SJ, Achinger-Kawecka J. PMID: 42170760 [PubMed - as supplied by publisher]
	Effects of neoadjuvant novel endocrine therapy combined with prostatic artery embolization on SII, PNI, and bRFS in patients with prostate cancer. Am J Transl Res Zhao B, Li B, Jiang J, Ma Q, Zhang H, You J, Li K. PMID: 42170485 [PubMed]
	A case report of rectal squamous cell carcinoma following radiation therapy for prostate cancer: a management dilemma. J Gastrointest Oncol Nwokeocha SO, Kumar J, Soni R, Shah S, Patel AV. PMID: 42169951 [PubMed]
	A cohort study investigating differences in skeletal muscle mitochondrial function between prostate cancer patients and healthy controls. BMC Cancer Smart TF, Bass JJ, Crossland H, Cox J, Atherton PJ, Lund JN, Phillips BE. PMID: 42168935 [PubMed - as supplied by publisher]
	Robotics Is Not Important Because It Is Robotic: Re: Jeremy Y. Teoh, Francesco M. Bracco, Julius H. Wong, et al. A Novel Transurethral Robotic Platform for Performing En Bloc Resection of Bladder Tumour: Results from the First Phase of the VIABLE Trial. Eur Urol Oncol 2026;86:111-15. Eur Urol Oncol Güven S, Soyturk S, Herrmann T. PMID: 42168051 [PubMed - as supplied by publisher]
	Reply to Daoyuan Li's Words of Wisdom re: Bacillus Calmette-GuÃ©rin Plus Mitomycin Versus Bacillus Calmette-GuÃ©rin Alone for Bacillus Calmette GuÃ©rin-naÃ¯ve Non-Muscle-Invasive Bladder Cancer: A Randomised Phase 3 Trial (ANZUP 1301). Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2026.03.011. Eur Urol Hayne D, Zhang AY, Thomas H, Redfern AD, Davis ID, Stockler MR. PMID: 42168001 [PubMed - as supplied by publisher]
	Impact of intraoperative intravenous heparin bolus on clinical outcomes during radical nephrectomy and IVC tumor thrombectomy in renal cell carcinoma with level I-IV IVC thrombus: A multi-institutional study. Urol Oncol Aydin AM, Dehghanmanshadi A, Mukhtar V, Siegel ER, Moon S, Biben E, Patel K, Kuykendall K, Fang AM, Langford T, Gokden N, Chang D, Kwon D, Ferguson JE, Peyton CC. PMID: 42167989 [PubMed - as supplied by publisher]
	Is Perirenal Fat an Active Player in Renal Cell Carcinoma Tumorigenesis? A Radiologic-Pathologic Correlation Study. Fr J Urol Gökkurt Y, Karakan T, Kesero, Bayburtluo, Demir DÖ, Y, Kaçan T. PMID: 42167716 [PubMed - as supplied by publisher]

Articles 1 - 20 / 188054

Page 1 of 9403



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy